Chad Crawley, DO
Orthopaedic Surgery · Tulsa, OKNPI 1720282478
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Heron Therapeutics, Inc. at 51.4% of the total. 2025 is the largest year on record at $15,453, 5.2 times the $2,986 reported in 2019.
Across 78 payments — averaging $370.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heron Therapeutics, Inc.$15K
- Medical Device Business Services, Inc.$9K
- KCI USA, Inc.$2K
- Stryker$763
- Johnson & Johnson$671
- Pacira Pharmaceuticals Incorporated$545
- plus $617 from 5 others
What the payments were for
- Consulting fees$10,55037%
- Speaking & faculty fees$13,60047%
- Travel & lodging$2,5109%
- Food & beverage$2,2018%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heron Therapeutics, Inc. | 13 | $14,845 |
| Medical Device Business Services, Inc. | 15 | $9,419 |
| KCI USA, Inc. | 1 | $2,000 |
| Stryker | 24 | $763 |
| Johnson & Johnson(2 entities) | 4 | $671 |
| Pacira Pharmaceuticals Incorporated | 6 | $545 |
| Nextstep Arthropedix, LLC | 2 | $179 |
| Zimmer Biomet | 4 | $165 |
| Sanara Medtech Inc. | 2 | $146 |
| Smith+Nephew | 6 | $114 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,861 in reported general payments places this provider in the 85th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 521 | $4,914 |
| Diclofenac Sodium | 184 | $2,256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 156 | $1,529 |
| Doxycycline Hyclate | 30 | $542 |
| Amoxicillin | 58 | $151 |
| Oxycodone Hcl | 26 | $133 |
| Cyclobenzaprine Hcl | 26 | $119 |
| Tramadol Hcl | 18 | $77 |
| Clindamycin Hcl | 15 | $62 |
| Prednisone | 14 | $31 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Tulsa
- Yogesh MittalTulsa$6.6M
- Brian ChalkinTulsa$183K
- Kasra AhmadiniaTulsa$138K
- Sarat KunapuliTulsa$136K
- Keivan AbtahiTulsa$77K
- Rodney PlasterTulsa$61K
- Garrett WallerTulsa$52K
- Landon StallingsTulsa$46K
- Travis SmallTulsa$39K
- Blake ShockleyTulsa$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.